Skip to Main Content

Paper Details

KRCC1: A potential therapeutic target in ovarian cancer.
FASEB J
4
2020
CHK1, H2AX, HDAC, HDAC1, HDAC2, High-grade serous ovarian cancer, KRCC1, PP1CC, cancer, cells, chromatin, histones, lysine, lysine rich coiled-coil 1, ovarian cancer, patient, serine, serine-threonine phosphatase, threonine, tumor, tumors
Author NameAffiliation
Khader ShameerInstitute of Next Generation Healthcare (INGH), Icahn Institute for Data Science and Genomic Technology
Khader ShameerInstitute of Next Generation Healthcare (INGH), Icahn Institute for Data Science and Genomic Technology
Soumyajit Banerjee MustafiBurst Biologics (Smart Surgical Inc.)
Cristina IvanDepartment of Experimental Therapeutics & Center for RNA Interference and Non-coding RNA, The University of Texas M. D. Anderson Cancer Center
Da YangCenter for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh
Joel T DudleyInstitute of Next Generation Healthcare (INGH), Icahn Institute for Data Science and Genomic Technology
Joel T DudleyInstitute of Next Generation Healthcare (INGH), Icahn Institute for Data Science and Genomic Technology
  • 1 - 7

Datasets